Is Your Practice Ready for the Impact of Theranostics
Is Your Practice Ready for the Impact of Theranostics is organized by American Roentgen Ray Society (ARRS).
Expiration Date: September 18, 2032
Description:
Theranostics refers to the ability to diagnose and treat some types of cancers with medical isotopes. Through their exquisite sensitivity and specificity, Nuclear Theranostics, in combination with sophisticated and performant digital hybrid imagers (SPECT/CT, PET/CT, and PET/MR) have started to play a major role in precision medicine and imaging by significantly improving patient disease management, particularly in oncology.
Gain a better understanding of the current and future role of Theranostics in imaging and cancer patient management, particularly for those suffering from neuroendocrine and prostate cancers. The course will also give the attendees the practical and financial information relevant to setting up their Theranostics practice.
Learning Outcomes and Modules:
After completing this course, the learner should be able to:
• Explain the new field of Theranostics.
• Discuss the role of diagnostic and therapeutic radio-pharmaceutical in oncology.
• Illustrate the needs and requirements to establish a Nuclear Theranostics practice.
• Recognize the financial impact of Nuclear Theranostics in their practice.
• Describe the benefits of integrating Theranostics in their practice.